Literature DB >> 77846

Reaction mechanisms of beta1H globulin.

K Nagaki, K Iida, M Okubo, S Inai.   

Abstract

The reaction mechanisms of beta1H were studied. The generation of alternative pathway C3 and C5 convertases on the cell surface as well as in the fluid phase was inhibited by beta1H globulin. The cell preparation bearing the C3b site could bind beta1H with little effect on the C3b hemolytic activity. Bound beta1H was dissociated by the action of C3bINA and C3bINA-treated C3b bearing cell did not bind beta1H anymore. Cell-bound beta1H was also dissociated by the action of B (or Bb). From these and other results, the following conclusions were obtained. The C3b site-bearing cell could bind beta1H on the C3c region of C3b molecules facilitating the C3bINA action on C3b, and beta1H shared the same binding site with B (or Bb) inhibiting the generation of the alternative pathway convertases competitively.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77846     DOI: 10.1159/000232106

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  13 in total

1.  C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.

Authors:  H Kitamura; M Matsumoto; K Nagaki
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

2.  Inhibition of classical C5 convertase in the complement system by factor H.

Authors:  S Ito; N Tamura
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

3.  The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.

Authors:  R G DiScipio
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

4.  Isolation of two molecular populations of human complement factor H by hydrophobic affinity chromatography.

Authors:  J Ripoche; A Al Salihi; J Rousseaux; M Fontaine
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

5.  Study on C3-like factor in the serum of a C3-deficient subject.

Authors:  H Kitamura; H Nishimukai; Y Sano; K Nagaki
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

6.  Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H.

Authors:  J Alsenz; J D Lambris; T F Schulz; M P Dierich
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

7.  Polyanion-induced self-association of complement factor H.

Authors:  Michael K Pangburn; Nenoo Rawal; Claudio Cortes; M Nurul Alam; Viviana P Ferreira; Mark A L Atkinson
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

Review 8.  Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

Authors:  M C Pickering; H T Cook
Journal:  Clin Exp Immunol       Date:  2008-02       Impact factor: 4.330

9.  Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.

Authors:  B J De Cueninck; T K Eisenstein; T S McIntosh; G D Shockman; R M Swenson
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  Purification and structural studies on the complement-system control protein beta 1H (Factor H).

Authors:  R B Sim; R G DiScipio
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.